ObsEva SA Initiates Phase 3 Clinical Program for OBE2109 in Uterine Fibroids
Apr 25, 2017 11:01 am UTC| Business
- PRIMROSE 1 and PRIMROSE 2, pivotal Phase 3 clinical trials to assess efficacy and safety of novel oral GnRH receptor antagonist OBE2109 in patients with heavy menstrual bleeding associated with uterine fibroids - ...
ConnectWise Announces Free Remote Control Solution Offering
Apr 25, 2017 11:01 am UTC| Business
TAMPA, Fla., April 25, 2017 -- Technology solution providers (TSPs) now have access to a free version of ConnectWise ControlTM (formerly ScreenConnect), an all-in-one solution for remote support and remote access....
ConnectWise Announces Free Remote Control Solution Offering
Apr 25, 2017 11:01 am UTC| Business
TAMPA, Fla., April 25, 2017 -- Technology solution providers (TSPs) now have access to a free version of ConnectWise ControlTM (formerly ScreenConnect), an all-in-one solution for remote support and remote access....
Apr 25, 2017 11:01 am UTC| Business
SUGAR LAND, Texas, April 25, 2017 -- Team, Inc. (NYSE:TISI) announced today that it will issue its first quarter 2017 results after the market closes on Tuesday, May 9, 2017. In conjunction with this release, Team, Inc....
Apr 25, 2017 11:01 am UTC| Business
SUGAR LAND, Texas, April 25, 2017 -- Team, Inc. (NYSE:TISI) announced today that it will issue its first quarter 2017 results after the market closes on Tuesday, May 9, 2017. In conjunction with this release, Team, Inc....
Apr 25, 2017 11:01 am UTC| Business
SAN DIEGO, April 25, 2017 -- Kratos Defense Security Solutions, Inc. (NASDAQ:KTOS), a leading National Security Solutions provider, announced today that it will publish financial results for the first quarter 2017...
Apr 25, 2017 11:01 am UTC| Business
SAN DIEGO, April 25, 2017 -- Kratos Defense Security Solutions, Inc. (NASDAQ:KTOS), a leading National Security Solutions provider, announced today that it will publish financial results for the first quarter 2017...